Letter | Published:

HCG Stimulation of testicular LHRH-like activity

Abstract

It is well established that the administration of high doses of luteinizing hormone (LH) or human chorionic gonadotropin (HCG) to animals can impair gonadal function in both the male and female1. These effects can be duplicated by the administration of LH releasing hormone (LHRH) or its agonists to intact animals2–5, including man6. Somewhat surprisingly, recent results have demonstrated that similar impairment of gonadal function by LHRH and its agonists can be achieved in the absence of the pituitary (for review see ref. 7), and the demonstration of specific, high-affinity binding sites for LHRH and its agonists on ovarian luteal cells8 and on testicular Leydig cells9–11, could mean that LHRH-like factors are involved in the local regulation of the gonads. A further intriguing finding is the striking similarity between the direct, inhibitory effects of LHRH and LH/HCG on the gonads7; for example, both treatments reduce LH receptor numbers and the steroidogenic responsiveness of rat Leydig cells2,4,12,13. We now offer a possible explanation for this similarity by demonstrating that HCG treatment stimulates the testicular production of a biologically active LHRH-like factor, suggesting that the inhibitory actions of HCG on the Leydig cell may be mediated by the local production of this factor.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Catt, K. J., Harwood, J. P., Aguilera, G. & Dafau, M. L. Nature 280, 109–116 (1979).

  2. 2

    Labrie, F. et al. Int. J. Androl. Suppl. 2, 303–314 (1978).

  3. 3

    Sandow, J., von Rechenberg, W., Baeder, C. & Engelbart, K. Int. J. Fert. (in the press).

  4. 4

    Sharpe, R. M., Fraser, H. M. & Sandow, J. J. Endocr. 80, 249–257 (1979).

  5. 5

    Fraser, H. M. & Lincoln, G. A. Biol. Reprod. 22, 269–276 (1980).

  6. 6

    Bergquist, C., Nillius, S. J., Bergh, T., Skarin, G. & Wide, L. Acta endocr. copenh. 91, 601–608 (1979).

  7. 7

    Sharpe, R. M. Nature 286, 12–14 (1980).

  8. 8

    Clayton, R. N., Harwood, J. P. & Catt, K. J. Nature 282, 90–92 (1979).

  9. 9

    Labrie, F. et al. Int. J. Fert. (in the press).

  10. 10

    Clayton, R. N., Katikineni, M., Chan, V., Dufau, M. L. & Catt, K. J. Proc. natn. Acad. Sci. U.S.A. (in the press).

  11. 11

    Sharpe, R. M. & Fraser, H. M. Biochem. biophys. Res. Commun. 95, 256–262 (1980).

  12. 12

    Arimura, A., Serafini, P., Talbot, S. & Schally, A. V. Biochem. biophys. Res. Commun. 90, 687–693 (1979).

  13. 13

    Hsueh, A. J. W. & Erickson, G. F. Nature 281, 66–67 (1979).

  14. 14

    Sharpe, R. M. Biol. Reprod. 22, 851–858 (1980).

  15. 15

    Sharpe, R. M. J. Reprod. Fert. 55, 365–371 (1979).

  16. 16

    Sharpe, R. M. & Setchell, B. P. Int. J. Androl. abstr. (in the press).

  17. 17

    Ying, S.-Y. & Guillemin, R. C.r. hebd. Séanc. Acad. Sci., Paris D289, 943–946 (1979).

  18. 18

    Ying, S.-Y. & Guillemin, R. in Progm. Abstr. Am. Endocrine Soc. Abstr. 158 (June, 1980).

  19. 19

    Sharpe, R. M. & McNeilly, A. S. Molec. cell. Endocr. 18, 75–86 (1980).

  20. 20

    Miyachi, Y., Chrambach, A., Mecklenburg, R. & Lipsett, M. B. Endocrinology 92, 1725–1730 (1973).

  21. 21

    Sharpe, R. M., Shahmanesh, M., Ellwood, M. G., Hartog, M. & Brown, P. S. J. Endocr. 65, 265–273 (1975).

  22. 22

    Fraser, H. M. & Sandow, J. J. Endocr. 74, 291–296 (1977).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.